INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2000

Black currant anthocyanosides significantly lowered dark adaptation thresholds and improved visual fatigue symptoms in healthy humans.

In a double-blind, placebo-controlled crossover study, healthy humans were given black currant anthocyanosides (BCA) concentrate. BCA intake at three doses (12.5, 20, and 50 mg, n=12) appeared to dose-dependently lower the dark adaptation threshold, with a significant difference before vs. after intake at the 50 mg dose (p = 0.011). In a visual display terminal task (n=21), 50 mg BCA prevented a decrease in refraction values of the dominant eye compared to placebo (p = 0.064). Questionnaire assessment showed significant improvement in subjective asthenopia symptoms concerning the eye and lower back after BCA intake.

Study type
Double-blind, placebo-controlled crossover study
Who was studied
Healthy human subjects (n=12 in dark adaptation test; n=21 in refraction test)
What was measured
Dark adaptation threshold, transient refractive alteration, visual fatigue

THE PAPER

Effects of black current anthocyanoside intake on dark adaptation and VDT work-induced transient refractive alteration in healthy humans.

Nakaishi H, Matsumoto H, Tominaga S, Hirayama M. Altern Med Rev, 2000.

PubMed 11134978 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.